{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:07:24Z","timestamp":1793146044442,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["SUBZ.A430.25.079"],"award-info":[{"award-number":["SUBZ.A430.25.079"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14777-4","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T20:32:48Z","timestamp":1754512368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The examination of in vitro photosensitizing efficacy of aloe-emodin loaded liposome following photodynamic therapy on melanoma cell lines"],"prefix":"10.1038","volume":"15","author":[{"given":"Martyna","family":"Nowak-Perlak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Olszowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kupczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Wrze\u015bniok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Zaremba-Czogalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roksana","family":"D\u0119bicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Makarec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Gubernator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Zi\u00f3\u0142kowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Wo\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"key":"14777_CR1","doi-asserted-by":"publisher","unstructured":"Mattiuzzi, C. & Lippi, G. Current cancer epidemiology. J. Epidemiol. Global Health. 9 (4), 217. https:\/\/doi.org\/10.2991\/JEGH.K.191008.001 (2019).","DOI":"10.2991\/JEGH.K.191008.001"},{"key":"14777_CR2","doi-asserted-by":"publisher","unstructured":"Y\u00e9lamos, O., Geller, S. & Tokez, S. Skin cancer special issue in skin health and disease. Skin. Health Dis.. 3 (2). https:\/\/doi.org\/10.1002\/SKI2.224 (2023).","DOI":"10.1002\/SKI2.224"},{"key":"14777_CR3","doi-asserted-by":"publisher","unstructured":"Leiter, U., Keim, U. & Garbe, C. Epidemiology of Skin Cancer: Update 2019, Advances in experimental medicine and biology, vol. 1268, pp. 123\u2013139, https:\/\/doi.org\/10.1007\/978-3-030-46227-7_6  (2020).","DOI":"10.1007\/978-3-030-46227-7_6"},{"key":"14777_CR4","unstructured":"https:\/\/www.aimatmelanoma.org\/facts-statistics\/ [database 24.06.2025]."},{"key":"14777_CR5","doi-asserted-by":"publisher","unstructured":"Goyal, N., Thatai, P. & Sapra, B. Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery. Therapeutic Delivery. 8 (5), 265\u2013287. https:\/\/doi.org\/10.4155\/TDE-2016-0093 (2017).","DOI":"10.4155\/TDE-2016-0093"},{"key":"14777_CR6","doi-asserted-by":"publisher","unstructured":"Hasan, N. et al. Skin cancer: Understanding the journey of transformation from conventional to advanced treatment approaches. Mol. Cancer. 22 (1), 168. https:\/\/doi.org\/10.1186\/S12943-023-01854-3 (2023).","DOI":"10.1186\/S12943-023-01854-3"},{"key":"14777_CR7","doi-asserted-by":"publisher","unstructured":"Donohoe, C., Senge, M. O., Arnaut, L. G. & Gomes-da-Silva, L. C. Cell death in photodynamic therapy: From oxidative stress to anti-tumor immunity, Biochimica et biophysica acta. Reviews on cancer, vol. 1872, no. 2,  https:\/\/doi.org\/10.1016\/J.BBCAN.2019.07.003 (2019).","DOI":"10.1016\/J.BBCAN.2019.07.003"},{"key":"14777_CR8","doi-asserted-by":"publisher","unstructured":"Bacellar, I. O. L., Tsubone, T. M., Pavani, C. & Baptista, M. S. Photodynamic Efficiency: From Molecular Photochemistry to Cell Death, International journal of molecular sciences, vol. 16, no. 9, pp. 20523\u201320559, https:\/\/doi.org\/10.3390\/IJMS160920523 (2015).","DOI":"10.3390\/IJMS160920523"},{"key":"14777_CR9","doi-asserted-by":"publisher","unstructured":"Allegra, A., Pioggia, G., Tonacci, A., Musolino, C. & Gangemi, S. Oxidative stress and photodynamic therapy of skin cancers: mechanisms, challenges and promising developments. Antioxidants 9 (5). https:\/\/doi.org\/10.3390\/ANTIOX9050448 (2020).","DOI":"10.3390\/ANTIOX9050448"},{"key":"14777_CR10","doi-asserted-by":"publisher","unstructured":"\u015eeker Karatoprak, G. et al. Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer, Oxidative Med. Cell.  Longevity https:\/\/doi.org\/10.1155\/2022\/7928200 (2022)","DOI":"10.1155\/2022\/7928200"},{"key":"14777_CR11","doi-asserted-by":"publisher","unstructured":"Nowak-Perlak, M., Zi\u00f3\u0142kowski, P. & Wo\u017aniak, M. A promising natural anthraquinones mediated by photodynamic therapy for anti-cancer therapy. Phytomedicine: Int. J. Phytotherapy Phytopharmacology. 119 https:\/\/doi.org\/10.1016\/J.PHYMED.2023.155035 (2023).","DOI":"10.1016\/J.PHYMED.2023.155035"},{"key":"14777_CR12","doi-asserted-by":"publisher","unstructured":"Chou, T. H. & Liang, C. H. The molecular effects of aloe-emodin (AE)\/liposome-AE on human nonmelanoma skin cancer cells and skin permeation. Chem. Res. Toxicol. 22 (12), 2017\u20132028. https:\/\/doi.org\/10.1021\/TX900318A (2009).","DOI":"10.1021\/TX900318A"},{"key":"14777_CR13","doi-asserted-by":"publisher","unstructured":"Guimar\u00e3es, D., Cavaco-Paulo, A. & Nogueira, E. Design of liposomes as drug delivery system for therapeutic applications. Int. J. Pharm. 601 https:\/\/doi.org\/10.1016\/J.IJPHARM.2021.120571 (2021).","DOI":"10.1016\/J.IJPHARM.2021.120571"},{"key":"14777_CR14","doi-asserted-by":"publisher","unstructured":"Gibot, L. et al. Role of polymer micelles in the delivery of photodynamic therapy agent to liposomes and cells. Cancers 12 (2). https:\/\/doi.org\/10.3390\/CANCERS12020384 (2020).","DOI":"10.3390\/CANCERS12020384"},{"key":"14777_CR15","doi-asserted-by":"publisher","unstructured":"Carita, A. C., Eloy, J. O., Chorilli, M., Lee, R. J. & Leonardi, G. R. Recent advances and perspectives in liposomes for cutaneous drug delivery. Curr. Med. Chem. 25 (5), 606\u2013635. https:\/\/doi.org\/10.2174\/0929867324666171009120154 (2018).","DOI":"10.2174\/0929867324666171009120154"},{"key":"14777_CR16","doi-asserted-by":"publisher","unstructured":"Clark, W. H., Elder, D. E. & Van Horn, M. The biologic forms of malignant melanoma. Hum. Pathol. 17 (5), 443\u2013450. https:\/\/doi.org\/10.1016\/S0046-8177(86)80032-6 (1986).","DOI":"10.1016\/S0046-8177(86)80032-6"},{"key":"14777_CR17","doi-asserted-by":"publisher","unstructured":"Bastian, B. C. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu. Rev. Pathol. 9 (1), 239\u2013271. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104658 (2014).","DOI":"10.1146\/annurev-pathol-012513-104658"},{"key":"14777_CR18","doi-asserted-by":"publisher","unstructured":"BOBOS, M. Histopathologic classification and prognostic factors of melanoma: a 2021 update. Italian J. Dermatology Venereol. 156 (3). https:\/\/doi.org\/10.23736\/S2784-8671.21.06958-3 (2021).","DOI":"10.23736\/S2784-8671.21.06958-3"},{"key":"14777_CR19","doi-asserted-by":"publisher","unstructured":"Wagstaff, W. et al. Nov., Melanoma: Molecular genetics, metastasis, targeted therapies, immunotherapies, and therapeutic resistance, Genes Dis, vol. 9, no. 6, pp. 1608\u20131623, https:\/\/doi.org\/10.1016\/j.gendis.2022.04.004 (2022).","DOI":"10.1016\/j.gendis.2022.04.004"},{"key":"14777_CR20","doi-asserted-by":"publisher","unstructured":"Cowled, P. A., Mackenzie, L. & Forbes, I. J. Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids. Cancer Lett. 29 (1), 107\u2013114. https:\/\/doi.org\/10.1016\/0304-3835(85)90130-2 (1985).","DOI":"10.1016\/0304-3835(85)90130-2"},{"key":"14777_CR21","doi-asserted-by":"publisher","unstructured":"McCaughan, J. S. Photodynamic therapy for esophageal tumors. Arch. Surg. 124 (1), 74. https:\/\/doi.org\/10.1001\/archsurg.1989.01410010084018 (1989).","DOI":"10.1001\/archsurg.1989.01410010084018"},{"key":"14777_CR22","doi-asserted-by":"publisher","unstructured":"Jmor, F., Hussain, R. N., Damato, B. E. & Heimann, H. Photodynamic therapy as initial treatment for small choroidal melanomas. Photodiagnosis Photodyn Ther. 20, 175\u2013181. https:\/\/doi.org\/10.1016\/j.pdpdt.2017.10.018 (2017).","DOI":"10.1016\/j.pdpdt.2017.10.018"},{"key":"14777_CR23","doi-asserted-by":"publisher","unstructured":"Buszman, E., Beberok, A., R\u00f3za\u0144ska, R. & Orzechowska, A. Interaction of chlorpromazine, fluphenazine and trifluoperazine with ocular and synthetic melanin in vitro. Pharmazie 63 (5), 372\u2013376. https:\/\/doi.org\/10.1691\/PH.2008.7663 (2008).","DOI":"10.1691\/PH.2008.7663"},{"key":"14777_CR24","doi-asserted-by":"publisher","unstructured":"Rok, J., Rzepka, Z., Respondek, M., Beberok, A. & Wrze\u015bniok, D. Chlortetracycline and melanin biopolymer - The risk of accumulation and implications for phototoxicity: an in vitro study on normal human melanocytes. Chemico-Biol. Interact. 303, 27\u201334. https:\/\/doi.org\/10.1016\/J.CBI.2019.02.005 (2019).","DOI":"10.1016\/J.CBI.2019.02.005"},{"key":"14777_CR25","doi-asserted-by":"publisher","unstructured":"Nowak-Perlak, M., Bromke, M. A., Zi\u00f3\u0142kowski, P. & Wo\u017aniak, M. The comparison of the efficiency of Emodin and Aloe-Emodin in photodynamic therapy. Int. J. Mol. Sci. 23 (11). https:\/\/doi.org\/10.3390\/IJMS23116276 (2022).","DOI":"10.3390\/IJMS23116276"},{"key":"14777_CR26","doi-asserted-by":"publisher","unstructured":"Liu, J., Wu, F. & Chen, C. Design and synthesis of aloe-emodin derivatives as potent anti-tyrosinase, antibacterial and anti-inflammatory agents, Bioorganic & medicinal chemistry letters, vol. 25, no. 22, pp. 5142\u20135146, https:\/\/doi.org\/10.1016\/J.BMCL.2015.10.004 (2015).","DOI":"10.1016\/J.BMCL.2015.10.004"},{"issue":"6","key":"14777_CR27","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1038\/JID.2014.65","volume":"134","author":"L Denat","year":"2014","unstructured":"Denat, L., Kadekaro, A. L., Marrot, L., Leachman, S. A. & Abdel-Malek, Z. A. Melanocytes as instigators and victims of oxidative stress. J. Invest. Dermatol. 134 (6), 1512\u20131518. https:\/\/doi.org\/10.1038\/JID.2014.65 (2014).","journal-title":"J. Invest. Dermatol."},{"key":"14777_CR28","doi-asserted-by":"publisher","unstructured":"Rok, J., Rzepka, Z., Maszczyk, M., Beberok, A. & Wrze\u015bniok, D. Minocycline Impact on Redox Homeostasis of Normal Human Melanocytes HEMn-LP Exposed to UVA Radiation and Hydrogen Peroxide, International journal of molecular sciences, vol. 22, no. 4, pp. 1\u201321, https:\/\/doi.org\/10.3390\/IJMS22041642 (2021).","DOI":"10.3390\/IJMS22041642"},{"key":"14777_CR29","doi-asserted-by":"publisher","unstructured":"Kumari, J., Das, K., Babaei, M., Rokni, G. R. & Goldust, M. The impact of blue light and digital screens on the skin, Journal of cosmetic dermatology, vol. 22, no. 4, pp. 1185\u20131190,https:\/\/doi.org\/10.1111\/JOCD.15576 (2023).","DOI":"10.1111\/JOCD.15576"},{"key":"14777_CR30","doi-asserted-by":"publisher","unstructured":"Kim, J. H. et al. Tyrosinase inhibitory components from Aloe Vera and their antiviral activity. J. Enzyme Inhib. Med. Chem. 32 (1), 78\u201383. https:\/\/doi.org\/10.1080\/14756366.2016.1235568 (2017).","DOI":"10.1080\/14756366.2016.1235568"},{"key":"14777_CR31","doi-asserted-by":"publisher","unstructured":"Chen, Q. et al. Exploring a novel target treatment on breast cancer: Aloe-emodin mediated photodynamic therapy induced cell apoptosis and inhibited cell metastasis. Anticancer Agents Med. Chem. 16 (6), 763\u2013770. https:\/\/doi.org\/10.2174\/1871520615666150821093323 (2016).","DOI":"10.2174\/1871520615666150821093323"},{"key":"14777_CR32","doi-asserted-by":"publisher","unstructured":"Odhiambo, W. O. et al. Aloe-Emodin-Mediated Photodynamic Therapy Induces Apoptosis in Basal Cell Carcinoma Cells via Activation of ERK\/JNK Signaling Pathway, International Journal of Photoenergy, vol. pp. 1\u201310,  https:\/\/doi.org\/10.1155\/2021\/6935269 (2021).","DOI":"10.1155\/2021\/6935269"},{"key":"14777_CR33","doi-asserted-by":"publisher","unstructured":"P. TU et al., Aloe-emodin-mediated photodynamic therapy induces autophagy and apoptosis in human osteosarcoma cell line MG-63 through the ROS\/JNK signaling pathway. Oncol. Rep., 35, 6, pp. 3209\u20133215, https:\/\/doi.org\/10.3892\/or.2016.4703 (2016)","DOI":"10.3892\/or.2016.4703"},{"key":"14777_CR34","doi-asserted-by":"publisher","unstructured":"Bennett, D. C. Genetics of melanoma progression: the rise and fall of cell senescence, Pigment Cell Melanoma Res, vol. 29, no. 2, pp. 122\u2013140, https:\/\/doi.org\/10.1111\/pcmr.12422 (2016).","DOI":"10.1111\/pcmr.12422"},{"key":"14777_CR35","doi-asserted-by":"publisher","unstructured":"Li, X. Y. et al. Susceptibility and resistance mechanisms during photodynamic therapy of melanoma. Front. Oncol. 10 https:\/\/doi.org\/10.3389\/FONC.2020.00597 (2020).","DOI":"10.3389\/FONC.2020.00597"},{"key":"14777_CR36","doi-asserted-by":"publisher","unstructured":"Honors, C. N., Kruger, C. A. & Abrahamse, H. Photodynamic Therapy for Metastatic Melanoma Treatment: A Review, Technology in cancer research & treatment, vol. 17, https:\/\/doi.org\/10.1177\/1533033818791795 (2018).","DOI":"10.1177\/1533033818791795"},{"key":"14777_CR37","doi-asserted-by":"publisher","unstructured":"Dudzik, T., Doma\u0144ski, I. & Makuch, S. The impact of photodynamic therapy on immune system in cancer - an update. Front. Immunol. 15 https:\/\/doi.org\/10.3389\/FIMMU.2024.1335920 (2024).","DOI":"10.3389\/FIMMU.2024.1335920"},{"key":"14777_CR38","doi-asserted-by":"publisher","unstructured":"Kwak, M. S. et al. Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology, Frontiers in immunology, vol. 11,   https:\/\/doi.org\/10.3389\/FIMMU.2020.01189 (2020).","DOI":"10.3389\/FIMMU.2020.01189"},{"key":"14777_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2147\/JIR.S386898","volume":"16","author":"H Guan","year":"2023","unstructured":"Guan, H. et al. The comprehensive role of high mobility group box 1 (HMGB1) protein in different tumors: A Pan-Cancer analysis. J. Inflamm. Res. 16, 617\u2013637. https:\/\/doi.org\/10.2147\/JIR.S386898 (2023).","journal-title":"J. Inflamm. Res."},{"key":"14777_CR40","doi-asserted-by":"publisher","unstructured":"Wen, J. & Zhang, X. HMGB1 Signaling-Mediated Tumor Immunity in Cancer Progress, Frontiers in bioscience (Landmark edition), vol. 28, no. 10, https:\/\/doi.org\/10.31083\/J.FBL2810260 (2023).","DOI":"10.31083\/J.FBL2810260"},{"key":"14777_CR41","doi-asserted-by":"publisher","unstructured":"Raucci, A., Palumbo, R. & Bianchi, M. E. HMGB1: a signal of necrosis, Autoimmunity, vol. 40, no. 4, pp. 285\u2013289, https:\/\/doi.org\/10.1080\/08916930701356978 (2007).","DOI":"10.1080\/08916930701356978"},{"issue":"15","key":"14777_CR42","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.18632\/ONCOTARGET.2201","volume":"5","author":"Q Li","year":"2014","unstructured":"Li, Q. et al. Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1\/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway. Oncotarget 5 (15), 6387\u20136403. https:\/\/doi.org\/10.18632\/ONCOTARGET.2201 (2014).","journal-title":"Oncotarget"},{"key":"14777_CR43","doi-asserted-by":"publisher","unstructured":"Li Pomi, F. et al. Role of HMGB1 in cutaneous melanoma: state of the Art. Int. J. Mol. Sci. 23 (16). https:\/\/doi.org\/10.3390\/IJMS23169327 (2022).","DOI":"10.3390\/IJMS23169327"},{"key":"14777_CR44","doi-asserted-by":"publisher","unstructured":"Ranzato, E., Martinotti, S. & Patrone, M. Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. ImmunoTargets Therapy. 4, 101. https:\/\/doi.org\/10.2147\/ITT.S58064 (2015).","DOI":"10.2147\/ITT.S58064"},{"key":"14777_CR45","doi-asserted-by":"publisher","unstructured":"Korbelik, M., Zhang, W. & Merchant, S. Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release, Cancer immunology, immunotherapy: CII, vol. 60, no. 10, pp. 1431\u20131437, https:\/\/doi.org\/10.1007\/S00262-011-1047-X (2011).","DOI":"10.1007\/S00262-011-1047-X"},{"key":"14777_CR46","doi-asserted-by":"publisher","unstructured":"Wiersma, V. R., Michalak, M., Abdullah, T. M., Bremer, E. & Eggleton, P. Mechanisms of translocation of ER chaperones to the cell surface and Immunomodulatory roles in cancer and autoimmunity. Front. Oncol. 5, 1\u201314. https:\/\/doi.org\/10.3389\/FONC.2015.00007 (2015).","DOI":"10.3389\/FONC.2015.00007"},{"key":"14777_CR47","doi-asserted-by":"publisher","unstructured":"Morais, J. A. V., Almeida, L. R., Rodrigues, M. C., Azevedo, R. B. & Muehlmann, L. A. The induction of immunogenic cell death by photodynamic therapy in B16F10 cells in vitro is effected by the concentration of the photosensitizer, Photodiagnosis and photodynamic therapy, vol. 35, https:\/\/doi.org\/10.1016\/J.PDPDT.2021.102392 (2021).","DOI":"10.1016\/J.PDPDT.2021.102392"},{"key":"14777_CR48","doi-asserted-by":"publisher","unstructured":"Lifshits, L. M. et al. Nov., Near-infrared absorbing Ru(ii) complexes act as immunoprotective photodynamic therapy (PDT) agents against aggressive melanoma, Chemical science, vol. 11, no. 43, pp. 11740\u201311762,https:\/\/doi.org\/10.1039\/D0SC03875J (2020).","DOI":"10.1039\/D0SC03875J"},{"key":"14777_CR49","unstructured":"Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response - PubMed. Accessed: Aug. 25, [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/15705903\/ (2024)."},{"key":"14777_CR50","doi-asserted-by":"publisher","unstructured":"Premji, T. P., Dash, B. S., Das, S. & Chen, J. P. Functionalized nanomaterials for inhibiting ATP-Dependent heat shock proteins in cancer photothermal\/photodynamic therapy and combination therapy. Nanomaterials (Basel Switzerland). 14 (1). https:\/\/doi.org\/10.3390\/NANO14010112 (2024).","DOI":"10.3390\/NANO14010112"},{"key":"14777_CR51","doi-asserted-by":"publisher","unstructured":"Hanlon, J. G. et al. Induction of Hsp60 by Photofrin-mediated photodynamic therapy, Journal of photochemistry and photobiology. B, vol. 64, no. 1, pp. 55\u201361, https:\/\/doi.org\/10.1016\/S1011-1344(01)00189-0 (2001).","DOI":"10.1016\/S1011-1344(01)00189-0"},{"key":"14777_CR52","doi-asserted-by":"publisher","unstructured":"Helbig, D., Simon, J. C. & Paasch, U. Photodynamic therapy and the role of heat shock protein 70, International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, vol. 27, no. 8, pp. 802\u2013810,  https:\/\/doi.org\/10.3109\/02656736.2011.569966 (2011).","DOI":"10.3109\/02656736.2011.569966"},{"key":"14777_CR53","doi-asserted-by":"publisher","unstructured":"Kaneko, K. et al. Heat shock protein 90-targeted photodynamic therapy enables treatment of subcutaneous and visceral tumors. Commun. Biology. 3 (1). https:\/\/doi.org\/10.1038\/S42003-020-0956-7 (2020).","DOI":"10.1038\/S42003-020-0956-7"},{"issue":"3","key":"14777_CR54","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/J.BBAMCR.2011.08.007","volume":"1823","author":"DC Altieri","year":"2012","unstructured":"Altieri, D. C., Stein, G. S., Lian, J. B. & Languino, L. R. TRAP-1, the mitochondrial Hsp90. Biochim. Biophys. Acta. 1823 (3), 767\u2013773. https:\/\/doi.org\/10.1016\/J.BBAMCR.2011.08.007 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"14777_CR55","doi-asserted-by":"publisher","unstructured":"Thomas, A. P. et al. Mitochondrial heat shock protein-guided photodynamic therapy, Chemical communications (Cambridge, England), vol. 55, no. 84, pp. 12631\u201312634, https:\/\/doi.org\/10.1039\/C9CC06411G (2019).","DOI":"10.1039\/C9CC06411G"},{"issue":"9","key":"14777_CR56","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1039\/C6PP00097E","volume":"15","author":"ME Rodr\u00edguez","year":"2016","unstructured":"Rodr\u00edguez, M. E., Cogno, I. S., Milla Sanabria, L. S., Mor\u00e1n, Y. S. & Rivarola, V. A. Heat shock proteins in the context of photodynamic therapy: autophagy, apoptosis and Immunogenic cell death. Photochemical Photobiological Sciences: Official J. Eur. 15 (9), 1090\u20131102. https:\/\/doi.org\/10.1039\/C6PP00097E (2016).","journal-title":"Photochemical Photobiological Sciences: Official J. Eur."},{"key":"14777_CR57","doi-asserted-by":"publisher","unstructured":"Didelot, C. et al. Oct., Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins, Current medicinal chemistry, vol. 14, no. 27, pp. 2839\u20132847,https:\/\/doi.org\/10.2174\/092986707782360079 (2007).","DOI":"10.2174\/092986707782360079"},{"issue":"23","key":"14777_CR58","doi-asserted-by":"publisher","first-page":"11897","DOI":"10.18632\/ONCOTARGET.2472","volume":"5","author":"G Guzzo","year":"2014","unstructured":"Guzzo, G., Sciacovelli, M., Bernardi, P. & Rasola, A. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells. Oncotarget 5 (23), 11897\u201311908. https:\/\/doi.org\/10.18632\/ONCOTARGET.2472 (2014).","journal-title":"Oncotarget"},{"key":"14777_CR59","doi-asserted-by":"publisher","unstructured":"Matassa, D. S., Agliarulo, I., Avolio, R., Landriscina, M. & Esposito, F. TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor, Genes, vol. 9, no. 4,  https:\/\/doi.org\/10.3390\/GENES9040195 (2018).","DOI":"10.3390\/GENES9040195"},{"issue":"1","key":"14777_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.YDBIO.2011.06.043","volume":"358","author":"S Saha","year":"2011","unstructured":"Saha, S. & Kashina, A. Posttranslational arginylation as a global biological regulator. Dev. Biol. 358 (1), 1\u20138. https:\/\/doi.org\/10.1016\/J.YDBIO.2011.06.043 (2011).","journal-title":"Dev. Biol."},{"key":"14777_CR61","doi-asserted-by":"publisher","unstructured":"Han, A. et al. Calreticulin is a critical cell survival factor in malignant neoplasms. PLoS Biol. 17 (9). https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.3000402 (2019).","DOI":"10.1371\/JOURNAL.PBIO.3000402"},{"key":"14777_CR62","doi-asserted-by":"publisher","unstructured":"Fucikova, J., Spisek, R., Kroemer, G. & Galluzzi, L. Calreticulin and cancer. Cell Res. 31 (1), 5\u201316. https:\/\/doi.org\/10.1038\/S41422-020-0383-9 (2021).","DOI":"10.1038\/S41422-020-0383-9"},{"key":"14777_CR63","doi-asserted-by":"publisher","unstructured":"Zhang, M. et al. Sep., Calreticulin as a marker and therapeutic target for cancer, Clinical and experimental medicine, vol. 23, no. 5, pp. 1393\u20131404,https:\/\/doi.org\/10.1007\/S10238-022-00937-7 (2023).","DOI":"10.1007\/S10238-022-00937-7"},{"issue":"2","key":"14777_CR64","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.canlet.2003.09.036","volume":"203","author":"J Dissemond","year":"2004","unstructured":"Dissemond, J. et al. Differential downregulation of Endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. Cancer Lett. 203 (2), 225\u2013231. https:\/\/doi.org\/10.1016\/j.canlet.2003.09.036 (2004).","journal-title":"Cancer Lett."},{"key":"14777_CR65","doi-asserted-by":"publisher","unstructured":"Thiruppathi, J., Vijayan, V., Park, I. K., Lee, S. E. & Rhee, J. H. Enhancing cancer immunotherapy with photodynamic therapy and nanoparticle: making tumor microenvironment hotter to make immunotherapeutic work better. Front. Immunol. 15 https:\/\/doi.org\/10.3389\/FIMMU.2024.1375767 (2024).","DOI":"10.3389\/FIMMU.2024.1375767"},{"key":"14777_CR66","doi-asserted-by":"publisher","unstructured":"Hua, J. et al. Current strategies for tumor photodynamic therapy combined with immunotherapy. Front. Oncol. 11 https:\/\/doi.org\/10.3389\/FONC.2021.738323 (2021).","DOI":"10.3389\/FONC.2021.738323"},{"key":"14777_CR67","doi-asserted-by":"publisher","unstructured":"Kaunitz, G. J. et al. Sep., Melanoma subtypes demonstrate distinct PD-L1 expression profiles, Laboratory investigation; a journal of technical methods and pathology, vol. 97, no. 9, pp. 1063\u20131071, https:\/\/doi.org\/10.1038\/LABINVEST.2017.64 (2017).","DOI":"10.1038\/LABINVEST.2017.64"},{"key":"14777_CR68","doi-asserted-by":"publisher","unstructured":"Lobo, C. S., Mendes, M. I. P., Pereira, D. A., Gomes-da-Silva, L. C. & Arnaut, L. G. Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming, Scientific reports, vol. 13, no. 1,  https:\/\/doi.org\/10.1038\/S41598-023-38862-8 (2023).","DOI":"10.1038\/S41598-023-38862-8"},{"key":"14777_CR69","doi-asserted-by":"publisher","unstructured":"Hwang, H. S. et al. Nov., Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression, Cells, vol. 9, no. 11, pp. 1\u201318, https:\/\/doi.org\/10.3390\/CELLS9112432 (2020).","DOI":"10.3390\/CELLS9112432"},{"key":"14777_CR70","doi-asserted-by":"publisher","unstructured":"Soliman, A. H., Youness, R. A., Sebak, A. A. & Handoussa, H. Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19\/iNOS\/PD-L1 axis, Photodiagnosis and photodynamic therapy, vol. 44, https:\/\/doi.org\/10.1016\/J.PDPDT.2023.103792 (2023).","DOI":"10.1016\/J.PDPDT.2023.103792"},{"key":"14777_CR71","doi-asserted-by":"publisher","unstructured":"Alia Moosavian, S., Hashemi, M., Etemad, L., Daneshmand, S. & Salmasi, Z. Melanoma-derived exosomes: Versatile extracellular vesicles for diagnosis, metastasis, immune modulation, and treatment of melanoma, International immunopharmacology, vol. 113, no. Pt A https:\/\/doi.org\/10.1016\/J.INTIMP.2022.109320 (2022).","DOI":"10.1016\/J.INTIMP.2022.109320"},{"key":"14777_CR72","doi-asserted-by":"publisher","unstructured":"Lattmann, E. & Levesque, M. P. The role of extracellular vesicles in melanoma progression. Cancers 14 (13). https:\/\/doi.org\/10.3390\/CANCERS14133086 (2022).","DOI":"10.3390\/CANCERS14133086"},{"key":"14777_CR73","doi-asserted-by":"publisher","unstructured":"Gowda, R. et al. The role of exosomes in metastasis and progression of melanoma. Cancer Treat. Rev. 85 https:\/\/doi.org\/10.1016\/J.CTRV.2020.101975 (2020).","DOI":"10.1016\/J.CTRV.2020.101975"},{"key":"14777_CR74","doi-asserted-by":"publisher","unstructured":"Zebrowska, A., Widlak, P., Whiteside, T. & Pietrowska, M. Signaling of Tumor-Derived sEV Impacts Melanoma Progression, International journal of molecular sciences, vol. 21, no. 14, pp. 1\u201321, https:\/\/doi.org\/10.3390\/IJMS21145066 (2020).","DOI":"10.3390\/IJMS21145066"},{"key":"14777_CR75","doi-asserted-by":"publisher","unstructured":"Mkhobongo, B., Chandran, R. & Abrahamse, H. The role of melanoma Cell-Derived exosomes (MTEX) and photodynamic therapy (PDT) within a tumor microenvironment. Int. J. Mol. Sci. 22 (18). https:\/\/doi.org\/10.3390\/IJMS22189726 (2021).","DOI":"10.3390\/IJMS22189726"},{"key":"14777_CR76","doi-asserted-by":"publisher","unstructured":"Sharma, P., Diergaarde, B., Ferrone, S., Kirkwood, J. M. & Whiteside, T. L. Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells. Sci. Rep. 10 (1). https:\/\/doi.org\/10.1038\/S41598-019-56542-4 (2020).","DOI":"10.1038\/S41598-019-56542-4"},{"key":"14777_CR77","doi-asserted-by":"publisher","unstructured":"Pietrowska, M. et al. Proteomic profile of melanoma cell-derived small extracellular vesicles in patients\u2019 plasma: a potential correlate of melanoma progression. J. Extracell. Vesicles. 10 (4). https:\/\/doi.org\/10.1002\/JEV2.12063 (2021).","DOI":"10.1002\/JEV2.12063"},{"key":"14777_CR78","doi-asserted-by":"publisher","unstructured":"Lupia, A. et al. Dec., CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells, The Journal of investigative dermatology, vol. 134, no. 12, pp. 2947\u20132956, (2014). https:\/\/doi.org\/10.1038\/JID.2014.258 (2014).","DOI":"10.1038\/JID.2014.258"},{"key":"14777_CR79","doi-asserted-by":"publisher","unstructured":"Theodoraki, M. N. et al. Plasma-derived exosomes reverse Epithelial-to-Mesenchymal transition after photodynamic therapy of patients with head and neck cancer. Oncoscience 5, 3\u20134. https:\/\/doi.org\/10.18632\/ONCOSCIENCE.410 (2018).","DOI":"10.18632\/ONCOSCIENCE.410"},{"key":"14777_CR80","doi-asserted-by":"publisher","unstructured":"Wan, Z. et al. ROS triggered local delivery of stealth exosomes to tumors for enhanced chemo\/photodynamic therapy. J. Nanobiotechnol. 20 (1). https:\/\/doi.org\/10.1186\/S12951-022-01591-7 (2022).","DOI":"10.1186\/S12951-022-01591-7"},{"key":"14777_CR81","doi-asserted-by":"publisher","unstructured":"Li, K. T. et al. The effect of Aloe emodin\u2013encapsulated nanoliposome-mediated r\u2010caspase\u20103 gene transfection and photodynamic therapy on human gastric cancer cells. Cancer Med. 5 (2), 361. https:\/\/doi.org\/10.1002\/CAM4.584 (2016).","DOI":"10.1002\/CAM4.584"},{"key":"14777_CR82","doi-asserted-by":"publisher","unstructured":"Jonkman, J. E. N. et al. An introduction to the wound healing assay using live-cell microscopy. Cell Adhes. Migr. 8 (5), 440. https:\/\/doi.org\/10.4161\/CAM.36224 (2014).","DOI":"10.4161\/CAM.36224"},{"key":"14777_CR83","doi-asserted-by":"publisher","unstructured":"McKinnon, K. M. Flow Cytometry: An Overview, Current protocols in immunology, vol. 120, p. 5.1.1,  https:\/\/doi.org\/10.1002\/CPIM.40 (2018).","DOI":"10.1002\/CPIM.40"},{"key":"14777_CR84","doi-asserted-by":"publisher","unstructured":"Shehat, M. G. & Tigno-Aranjuez, J. Flow Cytometric Measurement Of ROS Production In Macrophages In Response To Fc\u03b3R Cross-linking, Journal of visualized experiments: JoVE, vol. no. 145, https:\/\/doi.org\/10.3791\/59167 (2019).","DOI":"10.3791\/59167"},{"key":"14777_CR85","doi-asserted-by":"publisher","unstructured":"Kupczyk, P. et al. Feb., PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study, Cells, vol. 10, no. 2, pp. 1\u201321, https:\/\/doi.org\/10.3390\/CELLS10020286  (2021).","DOI":"10.3390\/CELLS10020286"},{"key":"14777_CR86","doi-asserted-by":"publisher","unstructured":"Kupczyk, P. et al. UCHL1\/PGP 9.5 dynamic in Neuro-Immune-Cutaneous milieu: focusing on axonal nerve terminals and epidermal keratinocytes in psoriatic itch. Biomed. Res. Int. 2018 https:\/\/doi.org\/10.1155\/2018\/7489316 (2018).","DOI":"10.1155\/2018\/7489316"},{"key":"14777_CR87","doi-asserted-by":"publisher","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods (San Diego, Calif.), vol. 25, no. 4, pp. 402\u2013408, https:\/\/doi.org\/10.1006\/METH.2001.1262 (2001).","DOI":"10.1006\/METH.2001.1262"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14777-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14777-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14777-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T20:32:49Z","timestamp":1754512369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14777-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14777"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14777-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confrmed that all authors have approved the manuscript for submission and publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"28833"}}